RITE RAPID INFUSION TECHNOLOGY Trademark

Trademark Overview

On Wednesday, December 9, 2020, a trademark application was filed for RITE RAPID INFUSION TECHNOLOGY with the United States Patent and Trademark Office. The USPTO has given the RITE RAPID INFUSION TECHNOLOGY trademark a serial number of 90369025. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 2, 2024. This trademark is owned by Orcosa Inc.. The RITE RAPID INFUSION TECHNOLOGY trademark is filed in the Pharmaceutical Products category with the following description:

drug delivery agents, both prescription and over-the counter, in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
rite rapid infusion technology

General Information

Serial Number90369025
Word MarkRITE RAPID INFUSION TECHNOLOGY
Filing DateWednesday, December 9, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 2, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2022

Trademark Statements

Goods and Servicesdrug delivery agents, both prescription and over-the counter, in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
NOT AVAILABLE"RAPID INFUSION TECHNOLOGY"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, February 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOrcosa Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628
Party NameOrcosa Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEwing, NJ 08628

Trademark Events

Event DateEvent Description
Saturday, December 12, 2020NEW APPLICATION ENTERED
Sunday, February 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 27, 2021ASSIGNED TO EXAMINER
Saturday, June 5, 2021NON-FINAL ACTION WRITTEN
Saturday, June 5, 2021NON-FINAL ACTION E-MAILED
Saturday, June 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 17, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, December 20, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, January 6, 2022TEAS PETITION TO REVIVE RECEIVED
Thursday, January 6, 2022PETITION TO REVIVE-GRANTED
Thursday, January 6, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 6, 2022NOTICE OF REVIVAL - E-MAILED
Tuesday, January 11, 2022ASSIGNED TO LIE
Tuesday, January 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 21, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, March 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, October 26, 2022SOU EXTENSION 1 FILED
Monday, November 28, 2022ABANDONMENT - NO USE STATEMENT FILED
Monday, November 28, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, December 22, 2022TEAS PETITION TO REVIVE RECEIVED
Thursday, December 22, 2022PETITION TO REVIVE-GRANTED
Thursday, December 22, 2022SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, December 22, 2022NOTICE OF REVIVAL - E-MAILED
Tuesday, February 21, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 23, 2023SOU EXTENSION 1 GRANTED
Friday, February 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023SOU EXTENSION 2 FILED
Monday, May 29, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, May 30, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, July 27, 2023TEAS PETITION TO REVIVE RECEIVED
Thursday, July 27, 2023PETITION TO REVIVE-GRANTED
Thursday, July 27, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Thursday, July 27, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, August 1, 2023SOU EXTENSION 2 GRANTED
Wednesday, August 2, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 26, 2023SOU EXTENSION 3 FILED
Monday, November 27, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, November 27, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 4, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, December 4, 2023PETITION TO REVIVE-GRANTED
Monday, December 4, 2023NOTICE OF REVIVAL - E-MAILED
Monday, December 4, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, December 4, 2023NOTICE OF REVIVAL - E-MAILED
Tuesday, December 19, 2023SOU EXTENSION 3 GRANTED
Wednesday, December 20, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 26, 2024SOU EXTENSION 4 FILED
Monday, May 27, 2024ABANDONMENT - NO USE STATEMENT FILED
Friday, July 12, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Thursday, July 18, 2024PETITION TO REVIVE-GRANTED
Thursday, July 18, 2024NOTICE OF REVIVAL - E-MAILED
Thursday, July 18, 2024TEAS PETITION TO REVIVE RECEIVED
Thursday, July 18, 2024SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, July 22, 2024SOU EXTENSION 4 GRANTED
Monday, July 22, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

technology infusion rapid rite active release controlled ingredients wide pharmaceuticals variety provide tablets both